Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections

JNJ-Q2 is a novel, fifth-generation fluoroquinolone that has excellent in vitro and in vivo activity against a variety of Gram-positive and Gram-negative organisms. In vitro studies indicate that JNJ-Q2 has potent activity against pathogens responsible for acute bacterial skin and skin structure inf...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Infect Drug Resist
Main Authors: Jones, Travis M, Johnson, Steven W, DiMondi, V Paul, Wilson, Dustin T
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2016
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4908938/
https://ncbi.nlm.nih.gov/pubmed/27354817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S105620
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares